Literature DB >> 22868867

Stroke: Treatment for acute stroke--the end of the citicoline saga.

Wayne M Clark, Tegan D Clark.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22868867     DOI： 10.1038/nrneurol.2012.166

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials.

Authors:  Antoni Dávalos; José Castillo; José Alvarez-Sabín; Julio J Secades; Joan Mercadal; Sonia López; Erik Cobo; Steven Warach; David Sherman; Wayne M Clark; Rafael Lozano
Journal:  Stroke       Date:  2002-12       Impact factor: 7.914

2.  A randomized dose-response trial of citicoline in acute ischemic stroke patients. Citicoline Stroke Study Group.

Authors:  W M Clark; S J Warach; L C Pettigrew; R E Gammans; L A Sabounjian
Journal:  Neurology       Date:  1997-09       Impact factor: 9.910

3.  A randomized efficacy trial of citicoline in patients with acute ischemic stroke.

Authors:  W M Clark; B J Williams; K A Selzer; R M Zweifler; L A Sabounjian; R E Gammans
Journal:  Stroke       Date:  1999-12       Impact factor: 7.914

4.  Citicoline for treatment of experimental focal ischemia: histologic and behavioral outcome.

Authors:  J Aronowski; R Strong; J C Grotta
Journal:  Neurol Res       Date:  1996-12       Impact factor: 2.448

5.  Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators.

Authors:  S Warach; L C Pettigrew; J F Dashe; P Pullicino; D M Lefkowitz; L Sabounjian; K Harnett; U Schwiderski; R Gammans
Journal:  Ann Neurol       Date:  2000-11       Impact factor: 10.422

6.  A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients.

Authors:  W M Clark; L R Wechsler; L A Sabounjian; U E Schwiderski
Journal:  Neurology       Date:  2001-11-13       Impact factor: 9.910

7.  Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial).

Authors:  Antoni Dávalos; José Alvarez-Sabín; José Castillo; Exuperio Díez-Tejedor; Jose Ferro; Eduardo Martínez-Vila; Joaquín Serena; Tomás Segura; Vitor T Cruz; Jaime Masjuan; Erik Cobo; Julio J Secades
Journal:  Lancet       Date:  2012-06-11       Impact factor: 79.321

8.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

9.  Liposomes as in-vivo carriers for citicoline: effects on rat cerebral post-ischaemic reperfusion.

Authors:  M Fresta; G Puglisi; C Di Giacomo; A Russo
Journal:  J Pharm Pharmacol       Date:  1994-12       Impact factor: 3.765

10.  Treatment of acute cerebral infarction with a choline precursor in a multicenter double-blind placebo-controlled study.

Authors:  Y Tazaki; F Sakai; E Otomo; T Kutsuzawa; M Kameyama; T Omae; M Fujishima; A Sakuma
Journal:  Stroke       Date:  1988-02       Impact factor: 7.914
  10 in total
  6 in total

1.  Citicoline in stroke and TBI clinical trials.

Authors:  Rao Muralikrishna Adibhatla
Journal:  Nat Rev Neurol       Date:  2013-01-29       Impact factor: 42.937

2.  Potential efficacy of citicoline as adjunct therapy in treatment of cerebral malaria.

Authors:  Fatima El-Assaad; Valery Combes; Georges Emile Raymond Grau; Ronan Jambou
Journal:  Antimicrob Agents Chemother       Date:  2013-10-28       Impact factor: 5.191

Review 3.  Neuroprotective properties of citicoline: facts, doubts and unresolved issues.

Authors:  Pawel Grieb
Journal:  CNS Drugs       Date:  2014-03       Impact factor: 5.749

Review 4.  Liposomes and nanotechnology in drug development: focus on neurological targets.

Authors:  Pedro Ramos-Cabrer; Francisco Campos
Journal:  Int J Nanomedicine       Date:  2013-03-03

5.  Oxygen glucose deprivation/re-oxygenation-induced neuronal cell death is associated with Lnc-D63785 m6A methylation and miR-422a accumulation.

Authors:  Shu Xu; Ya Li; Ju-Ping Chen; Da-Zhuang Li; Qin Jiang; Ting Wu; Xiao-Zhong Zhou
Journal:  Cell Death Dis       Date:  2020-09-30       Impact factor: 8.469

6.  CPI-1189 protects neuronal cells from oxygen glucose deprivation/re-oxygenation-induced oxidative injury and cell death.

Authors:  Yong-Jun Li; Yueli Zhan; Chengrui Li; Jianhong Sun; Chengliang Yang
Journal:  Aging (Albany NY)       Date:  2021-02-17       Impact factor: 5.682
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.